Showing results (71-80 of 5,000) with videos related to
Sort By:
Pageof 500
American Journal of Clinical Oncology|August 7, 2003
Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomasCourtnay W Bloomer, Lawrence Kenyon, Elizabeth Hammond, et al.American Journal of Clinical Oncology|August 7, 2003
Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell linesLois M Witters, Jamie Crispino, Terri Fraterrigo, et al.American Journal of Clinical Oncology|August 7, 2003
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancerCarsten RoseAmerican Journal of Clinical Oncology|August 7, 2003
Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapyAngela H Brodie, Henning T MouridsenAmerican Journal of Clinical Oncology|August 7, 2003
Emerging role of aromatase inhibitors in the adjuvant settingPaul E GossAmerican Journal of Clinical Oncology|August 7, 2003
Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II studyNicolás Mohedano Mohedano, Pedro Sánchez Rovira, Ana Lozano Barriuso, et al.American Journal of Clinical Oncology|August 7, 2003
Pulmonary metastases tumor doubling time: assessment by computed tomographyRubens Chojniak, Riad N YounesAmerican Journal of Clinical Oncology|August 7, 2003
Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibodyShazia Ahmed, Aman Singh, John Krauss, et al.American Journal of Clinical Oncology|August 7, 2003
Role of radiotherapy in the treatment of neurosarcoidosisMichael D Menninger, Robert J Amdur, Robert B MarcusAmerican Journal of Clinical Oncology|December 1, 1987
Phase II study of aclarubicin in acute myeloblastic leukemiaD C Case, T J Ervin, M A Boyd, et al.Pageof 500